Logo | Name | Σ | ||
---|---|---|---|---|
Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3469 | 2587 | 832 | |
Pierre Fabre Laboratories New ways to care Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale … Sectors: Pharmaceutical | 742 | 550 | 146 | |
GSK We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines Sectors: Pharmaceutical | 1071 | 699 | 402 | |
Pharma IQ Equipping business leaders with indispensable insights and innovations to drive success in the pharmaceutical industry Pharma IQ, is the international online community focusing on providing pharmaceutical professionals with knowledge, information and insight. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community pharma, biotech, medical, smartlabs, elns, pharmaceuticals, life sciences, informatics, cold chain, pharma supply chain, temperature controlled logistics, medical devices, clinical r&d, clinical trials, pharma logistics, pharma regulations, contract manufacturing, cro, cmo, clinical research, and digital transformation Sectors: Pharmaceutical | 65 | 25 | 36 | |
Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: Biotechnology Pharmaceutical | 1561 | 1421 | 60 | |
Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: Biotechnology Pharmaceutical | 801 | 616 | 70 | |
Ceva Santé Animale Together, beyond animal health Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With more than 7,000 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: “Together, beyond animal health”. Our … Sectors: Animal Health Pharmaceutical | 294 | 134 | 151 | |
Syneos Health Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment. Clinical Trials and Biopharmaceutical Product Lifecycle Management Sectors: Pharmaceutical | 138 | 122 | 20 | |
Servier Pharmaceuticals Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to … Sectors: Pharmaceutical | 598 | 332 | 75 | |
Regeneron At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An … Sectors: Biotechnology Pharmaceutical | 358 | 273 | 22 | |
PharmaTimes Media Ltd Kickstarting healthcare conversations. Kickstarting healthcare conversations. PharmaTimes Magazine is the leading pharmaceutical magazine for senior decision makers in the pharma and healthcare industries. It is recognised for its wide-ranging coverage of the key developments facing this fast-paced sector, and its analytical, independent content. PharmaTimes Magazine has a dedicated staff of writers and editors who have many years' experience in writing and editing copy for pharma and healthcare readers in national newspapers, magazines and online. PharmaTimes Magazine readers range from pharmaceutical executives, to healthcare professionals (chief pharmacists, medicines management, academic health science networks and NHS commissioners), to government ministers. Available in … Sectors: Pharmaceutical | 109 | 103 | 9 | |
Pfizer We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them. Sectors: Pharmaceutical | 1358 | 1054 | 137 | |
Novo Nordisk Driving change to defeat serious chronic diseases, built upon our heritage in diabetes. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments … Sectors: Pharmaceutical | 1348 | 1100 | 144 | |
Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: Pharmaceutical | 1754 | 1559 | 123 | |
Mylan Follow us on our new journey as Viatris. www.linkedin.com/company/viatris We have combined with Upjohn, a legacy division of Pfizer, and are now Viatris. Follow along on our new journey as we empower people worldwide to live healthier at every stage of life. http://www.linkedin.com/company/viatris Sectors: Pharmaceutical | 30 | 9 | 19 | |
Moderna Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using … Sectors: Biotechnology Pharmaceutical | 700 | 549 | 84 | |
Incyte Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines. We are committed to the relentless pursuit of science that can improve the lives of patients. Our unique expertise in medicinal chemistry and biology has enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across Oncology and Inflammation & AutoImmunity. Headquartered in Wilmington, Delaware, Incyte has more than 1,700 employees and operations in North America, … Sectors: Pharmaceutical | 129 | 83 | 26 | |
AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: Pharmaceutical | 3776 | 2611 | 203 | |
Aspen Pharma Group Healthcare. We Care. With a 170-year heritage, Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets. We have approximately 9 100 employees at 69 established offices in over 50 countries and we improve the health of patients in more than 150 countries through our high quality, affordable medicines. Aspen focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through our key business segments. Our key business segments are Manufacturing and Commercial Pharmaceuticals comprising Regional Brands and Sterile Focus … Sectors: Pharmaceutical | 61 | 45 | 1 | |
Alexion Pharmaceuticals, Inc. Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex … Sectors: Biotechnology Pharmaceutical | 262 | 186 | 35 | |
AbbVie AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care Sectors: Pharmaceutical | 933 | 765 | 130 | |
Merck Group This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, … Tags: DAX30 Sectors: Biotechnology Pharmaceutical | 1477 | 862 | 336 | |
Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, … Sectors: Pharmaceutical | 383 | 330 | 55 | |
Laboratoire Aguettant Essential for Life Aguettant is a family-owned pharmaceutical company dedicated to the development, industrial production and distribution of innovative injectable pharmaceutical specialties that meet the demands and the needs of healthcare professionals and patients. Basé à Lyon en France, AGUETTANT est un laboratoire pharmaceutique familial dédié au développement, à la fabrication et à la commercialisation de spécialités pharmaceutiques injectables utilisées ou initiées à l’hôpital. Acteur européen reconnu, AGUETTANT met son expertise au service du progrès et de l’innovation médicale pour concevoir les solutions thérapeutiques de demain. Movement Disorder - Parkinson Injectable, Parenteral Essential Micro Nutrients (Trace Elements and Vitamins), Critical … Sectors: Pharmaceutical | 19 | 13 | 4 | |
Walgreens Boots Alliance Walgreens Boots Alliance (Nasdaq: WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. A trusted, global innovator in retail pharmacy with more than 12,500 locations across the U.S., Europe and Latin America, WBA plays a critical role in the healthcare ecosystem. The company is reimagining local healthcare and well-being for all as part of its purpose – to create more joyful lives through better health. Through dispensing medicines, improving access to a wide range of health services, providing high quality health and beauty products … Sectors: Pharmaceutical | 96 | 55 | 42 | |
MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: Pharmaceutical | 2106 | 1854 | 189 | |
Celgene We have merged with Bristol Myers Squibb creating a leading biopharma company, ideally positioned to discover, develop and deliver innovative medicines for patients fighting serious diseases. Visit www.bms.com to continue to learn more about our work to produce the next generation of medicines to treat cancer and other serious diseases. For more information on the acquisition, see our press release at: http://bit.ly/3UbQcnl Hematology, Oncology, Inflammation, Immunology, Cancer, R&D, Innovation, Immunooncology, biopharma, Epigenetics, Protein Homeostasis, Translation Medicine, and Orphan diseases Sectors: Pharmaceutical | 8 | 7 | 0 | |
Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: Pharmaceutical | 4519 | 2883 | 644 | |
Digital Pharma Lab [Automatic translation follows] Leading the digital innovation in the healthcare ecosystem We are leading the digital innovation in healthcare. Our mission is to unite healthcare professionals, manufacturers, startups and institutions around digital innovation and collective intelligence. Our approach, unique in Europe, allows all the players in the healthcare ecosystem to undertake, innovate, evolve and participate every day in building the healthcare of tomorrow. Together, beyond the limits 🚀 ______________________________________________________ ______________________________________________________ A pioneer in digital innovation in the healthcare ecosystem, we are a consulting firm dedicated to digital health and the transformation of the healthcare sector through collaboration and collective intelligence. … Sectors: Health Pharmaceutical | 209 | 59 | 168 | |
Boehringer Ingelheim Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: Animal Health Pharmaceutical | 1878 | 1262 | 258 | |
Takeda Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our … Sectors: Pharmaceutical | 982 | 699 | 263 | |
Shionogi & Co., Ltd Philosophy The purpose of the Shionogi Group's corporate activities is, as expressed in the opening of its Company Policy, to "supply the best possible medicine to protect the health and wellbeing of the patients we serve." This eternal and unwavering corporate philosophy is a statement of our vision and value to society. To achieve and live by the Company Policy, we have formulated Action Guidelines, which all Shionogi employees share and embrace as norms for daily activities. Through activities based on the Company Policy and the Action Guidelines, Shionogi will continue to contribute to patients, physicians and other healthcare providers, … Sectors: Pharmaceutical | 32 | 19 | 18 | |
Eisai Co., Ltd. At Eisai, human health care (hhc) is our goal. Eisai’s Corporate Concept is “to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides.” Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic … Sectors: Pharmaceutical | 21 | 17 | 2 | |
Astellas Pharma Astellas Pharma is a pharmaceutical company conducting business in approximately 70 countries around the world. At Astellas, we strive to be a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into the best outcomes for patients. Operating in approximately 70 countries with more than 14,000 employees, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines Pharmaceuticals and 医薬品 Sectors: Pharmaceutical | 112 | 76 | 23 | |
SEKISUI CHEMICAL Innovation for the Earth Plastics molding Sectors: Pharmaceutical | 4 | 3 | 0 | |
Otsuka Holdings Co., Ltd. [Automatic translation follows] 2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-0048 Sectors: Pharmaceutical | 0 | 0 | 0 | |
Daiichi Sankyo Passion for Innovation. Compassion for Patients. Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For all other inquiries about Daiichi Sankyo such as products or careers, please visit our website www.daiichisankyo.com. Please see below for global employment opportunities: Daiichi Sankyo … Sectors: Pharmaceutical | 17 | 12 | 1 | |
中外製薬 / Chugai Pharmaceutical Co., Ltd. [Automatic translation follows] Chugai Pharmaceutical (headquarters: Tokyo) is a research and development-based pharmaceutical company with strengths in its unique drug discovery technology platform, including antibody engineering technology. As an important member of the Roche Group and a listed company on the Tokyo Stock Exchange Prime Market, Chugai is committed to creating innovative medicines that meet unmet medical needs under an independent management system. Please refer to our Social Media Policy for use: https://www.chugai-pharm.co.jp/rule/sns/index.html Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai … Sectors: Pharmaceutical | 5 | 3 | 0 | |
Medtronic Engineering the extraordinary A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives. Sectors: Pharmaceutical | 969 | 878 | 27 | |
Bayer Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by … Tags: DAX30 Sectors: Chemistry Pharmaceutical | 4724 | 2889 | 637 | |
FirstWord Pharma Where people who know first, go first. FirstWord Pharma is a trusted news and analysis service that keeps pharmaceutical professionals up-to-date with the latest industry news and intelligence from across the globe. Fast and reliable news delivery of the latest developments in the pharma industry, with related analyses, physician polls and executive interviews to provide deeper insights. Never miss the critical developments shaping the industry with news and analysis delivered to your inbox daily. Register for our free daily industry newsletter at https://www.firstwordpharma.com/register FirstWord Pharma+, our personalized premium news service, allows you to monitor and track specific compounds/products, companies, medical … Sectors: Pharmaceutical | 55 | 20 | 35 | |
Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, … Sectors: Pharmaceutical | 1657 | 1072 | 127 | |
Teva Pharmaceuticals Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com. Please … Sectors: Pharmaceutical | 1860 | 1016 | 248 | |
Fresenius Medical Care Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases. We aim to create a future worth living for chronically and critically ill patients – worldwide and every day. Thanks to our decades of experience in dialysis, our innovative research and our value-based care approach, we can help them to enjoy the very best quality of life. Our portfolio encompasses a comprehensive range of high-quality health care products and services as well as various dialysis treatment options for both in-center and home dialysis that are individually tailored to our patients’ needs. dialysis, hemodialysis, … Tags: DAX30 Sectors: Pharmaceutical | 521 | 308 | 81 |